173 related articles for article (PubMed ID: 31382809)
1. Impact of rosuvastatin versus atorvastatin on coronary atherosclerotic plaque volume - a systematic review and meta-analysis with trial sequential analysis of randomized control trials.
Kumar A; Shariff M; Doshi R
Eur J Prev Cardiol; 2020 Dec; 27(19):2138-2141. PubMed ID: 31382809
[No Abstract] [Full Text] [Related]
2. Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization.
Thondapu V; Kurihara O; Yonetsu T; Russo M; Kim HO; Lee H; Soeda T; Minami Y; Jang IK
Am J Cardiol; 2019 May; 123(10):1565-1571. PubMed ID: 30851941
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques.
Qian C; Wei B; Ding J; Wu H; Cai X; Li B; Wang Y
Am J Cardiol; 2015 Nov; 116(10):1521-6. PubMed ID: 26385518
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
[TBL] [Abstract][Full Text] [Related]
6. Medical Therapy Induced Regression of Plaque in a Female Patient with ASCVD.
Guan S; Zhang Y; Wang B; Li W
Int Heart J; 2019 Jan; 60(1):175-177. PubMed ID: 30464115
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.
Otake H; Sugizaki Y; Toba T; Nagano Y; Tsukiyama Y; Yanaka KI; Yamamoto H; Nagasawa A; Onishi H; Takeshige R; Nakano S; Matsuoka Y; Tanimura K; Kawamori H; Shinke T; Hirata KI
J Cardiol; 2019 Mar; 73(3):228-232. PubMed ID: 30579806
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
[TBL] [Abstract][Full Text] [Related]
9. Efficacy comparison of rosuvastatin and atorvastatin in the treatment of atherosclerosis and drug safety analysis.
Liping Z; Xiufang L; Tao Y; Baomin Z; Houshuai T
Pak J Pharm Sci; 2018 Sep; 31(5(Special)):2203-2208. PubMed ID: 30463813
[TBL] [Abstract][Full Text] [Related]
10. Qualitative plaque stabilization but not quantitative plaque regression.
Nishigaki K
Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
[No Abstract] [Full Text] [Related]
11. Comparison between Atorvastatin and Rosuvastatin on Secondary Percutaneous Coronary Intervention Rate and the Risk Factors in Patients with Coronary Heart Disease.
Zhang J; Wang J; Yu H; Wang G; Zhang J; Zhu R; Liu X; Li J
Curr Drug Metab; 2020; 21(10):818-828. PubMed ID: 32156233
[TBL] [Abstract][Full Text] [Related]
12. Factors underlying regression of coronary atheroma with potent statin therapy.
Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis.
Jaam M; Al-Naimi HN; Haddad MM; Abushanab D; Al-Badriyeh D
J Comp Eff Res; 2023 Mar; 12(3):e220163. PubMed ID: 36847307
[No Abstract] [Full Text] [Related]
14. Effect of pitavastatin and atorvastatin on regression of atherosclerosis assessed using intravascular ultrasound: a meta-analysis.
Liu H; Zhang M; Li D; Tian J; Wang X; Pan J; Liu D; Li X; An F
Coron Artery Dis; 2018 Sep; 29(6):459-468. PubMed ID: 29738341
[TBL] [Abstract][Full Text] [Related]
15. Impact of renal function on changes of plaque characteristics in non-intervened coronary segments after rosuvastatin treatment in patients with angina pectoris and hypertension.
Hong YJ; Jeong MH; Cho KH; Kim MC; Lee KJ; Kim KH; Kim HK; Jeong HC; Park KH; Sim DS; Kim JH; Ahn Y; Cho JG; Park JC; Kim SH; Kang JC
Int J Cardiol; 2015; 187():286-7. PubMed ID: 25838233
[No Abstract] [Full Text] [Related]
16. A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles.
Takagi H; Umemoto T;
Am J Cardiol; 2014 Jan; 113(2):292-301. PubMed ID: 24230979
[TBL] [Abstract][Full Text] [Related]
17. A case of prominent coronary plaque regression with statin therapy.
Awaya T; Kodama C; Yamamoto M; Okazaki O; Hara H; Hiroi Y; Moroi M
J Cardiovasc Comput Tomogr; 2020; 14(3):275-276. PubMed ID: 31080108
[No Abstract] [Full Text] [Related]
18. Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia.
Ma Q; Zhou Y; Zhai G; Gao F; Zhang L; Wang J; Yang Q; Cheng W
Angiology; 2016 Jul; 67(6):526-35. PubMed ID: 26271127
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease.
Olszewska-Banaszczyk M; Jackowska P; Gorzelak-Pabiś P; Pytel E; Koter-Michalak M; Broncel M
Pharmacol Rep; 2018 Apr; 70(2):258-262. PubMed ID: 29475008
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic Change of Coronary Atherosclerotic Plaque After Statin Treatment: A Serial Follow-Up Study by Computed Tomography-Derived Fractional Flow Reserve.
Yu M; Dai X; Yu L; Lu Z; Shen C; Tao X; Zhang J
J Am Heart Assoc; 2020 May; 9(10):e015772. PubMed ID: 32384006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
